Kailera Therapeutics, Inc. Common Stock (KLRA) — Long-term Investment Intensity
Kailera Therapeutics, Inc. Common Stock (KLRA) has a Long-term Investment Intensity of 21.1% as of June 2026. Long-term investments of $255.08 Million represent 21.1% of total assets of $1.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check KLRA cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kailera Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Kailera Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 21.1%, reflecting long-term investments of $255.08 Million against total assets of $1.21 Billion USD. For the complete balance sheet picture, see Kailera Therapeutics, Inc. Common Stock assets under control.
Annual Long-term Investment Intensity for Kailera Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Kailera Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Kailera Therapeutics, Inc. Common Stock (KLRA) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 15.4% | $106.67 Million | $692.29 Million | — |